*Excellence in Clinical Care  * Excellence in Education   *Excellence in Research		Contact Us	Site Map

Stark Home Clinical Care   Clinical Services   Retinal Screening   Point of Care Lab   Foot care Education for patients   Diabetes Education   Diet Counseling   Online Resources for clinicians    Teleconference    Archived    Teleconferences    Resources Research     Clinical Trials     About us    Outreach    Mission    History    Staff    Donors    News    Contact Diabetes Warning Signs Frequent thirst Increased urination Blurred Vision Skin Infections Slow wound healing Increased tiredness Increased hunger Weight loss for no reason
		Teleconferences The Stark Diabetes Center conducts conferences and continuing medical education programs using telehealth technology. The twice-monthly conferences serve as forums for health care practitioners to discuss the latest therapies and discoveries about diabetes.   Archived Teleconference:   A Review of Diabetes Prevention Trials Kevin H. McKinney, M.D., FACE, FACP Associate Professor UTMB Division of Endocrinology Director, Adult Clinical Endocrinology October 17, 2006 12:00-1:00 P.M. Levin Hall 5th Floor Watch archived webcast (requires Internet Explorer and Windows Media Player) Objectives: Understand the medical consequences of impaired glucose tolerance   Understand the implications of recent diabetes prevention trials   Accreditation Statement: The University of Texas Medical Branch at Galveston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: The University of Texas Medical Branch at Galveston designates this educational activity for a maximum of 1 AMA PRA category 1 credit. Physicians should claim only credit commensurate with the extent of their participation in the activity. This program (#2005-676) has also been approved by the American Association of Critical-Care Nurses (AACN) – approved provider (#00012890) under established AACN guidelines for 1.0 contact hours, CERP Category A. Methodology: Lecture followed by question and answer session. Disclosure Statement: Dr. McKinney receives grant/research support from Novartis Pharmaceuticals and is on the Speakers Bureau of Amylin Pharmaceuticals.
updated 3/19/07